Ester Grilli

Ester Grilli

Auto-generated profile, based on publicly available information

Ester Grilli

Department of Veterinary Medical Sciences, University of Bologna, 40064 Bologna, Italy

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2019 in Microorganisms
Verified
Journal Article
Open access
PDF file
Christina SwaggertyChristina Swaggerty
Christina Swaggerty
Todd Riley CallawayTodd Riley Callaway
Todd Riley Callaway
Michael H. KogutMichael H. Kogut
Michael H. Kogut
APAndrea Piva
Andrea Piva
EGEster Grilli
Ester Grilli
Salmonella and Campylobacter are the two leading causes of bacterial-induced foodborne illness in the US. Food production animals including cattle, swine, and chickens are transmission sources for both pathogens. The number of Salmonella outbreaks attributed to poultry has decreased. However, the same cannot be said for Campylobacter where 50–70% of human cases result from poultry products. The poultry industry selects heavily on performance traits which adversely affects immune competence. Despite increasing demand for poultry, regulations and public outcry resulted in the ban of antibiotic growth promoters, pressuring the industry to find alternatives to manage flock health. One approach is to incorporate a program that naturally enhances/modulates the bird’s immune response. Immunomodulation of the immune system can be achieved using a targeted dietary supplementation and/or feed additive to alter immune function. Science-based modulation of the immune system targets ways to reduce inflammation, boost a weakened response, manage gut health, and provide an alternative approach to prevent disease and control foodborne pathogens when conventional methods are not efficacious or not available. The role of immunomodulation is just one aspect of an integrated, coordinated approach to produce healthy birds that are also safe and wholesome products for consumers.

30 April 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
JRJ Eduardo Rico
J Eduardo Rico
SSSina Saed Samii
Sina Saed Samii
YZYu (Patrick) Zang
Yu (Patrick) Zang
PDPragney Deme
Pragney Deme
NHNorman J. Haughey
Norman J. Haughey
JMJoseph McFadden
Joseph McFadden
The discovery of novel biomarkers for peripartal diseases in dairy cows can improve our understanding of normal and dysfunctional metabolism, and lead to nutritional interventions that improve health and milk production. Our objectives were to characterize the plasma lipidome and identify metabolites associated with common markers of metabolic disease in peripartal dairy cattle. Multiparous Holstein cows (n = 27) were enrolled 30 d prior to expected parturition. Blood and liver samples were routinely collected through to d 14 postpartum. Untargeted lipidomics was performed using quadrupole time-of-flight mass spectrometry. Based on postpartum measures, cows were categorized into low or high total fatty acid area under the curve (total FAAUC; d 1–14 postpartum; 4915 ± 1369 vs. 12,501 ± 2761 (μmol/L × 14 d); n = 18), β-hydroxybutyrate AUC (BHBAAUC; d 1–14 postpartum; 4583 ± 459 vs. 7901 ± 1206 (μmol/L × 14 d); n = 18), or liver lipid content (d 5 and 14 postpartum; 5 ± 1 vs. 12 ± 2% of wet weight; n = 18). Cows displayed decreases in plasma triacylglycerols and monoalkyl-diacylglycerols, and the majority of phospholipids reached a nadir at parturition. Phosphatidylcholines (PC) 32:3, 35:5, and 37:5 were specific for high total FAAUC, PC 31:3, 32:3, 35:5, and 37:5 were specific for high BHBAAUC, and PC 31:2, 31:3, and 32:3 were specific for high liver lipid content. PC 32:3 was specific for elevated total FA, BHBA, and liver lipid content. Lipidomics revealed a dynamic peripartal lipidome remodeling, and lipid markers associated with elevated total FA, BHBA, and liver lipid content. The effectiveness of nutrition to impact these lipid biomarkers for preventing excess lipolysis and fatty liver warrants evaluation.

14 December 2021 in Animals
Verified
Journal Article
Open access
PDF file
LKLayla King
Layla King
Janaka WickramasingheJanaka Wickramasinghe
Janaka Wickramasinghe
BDBrooke Dooley
Brooke Dooley
CMCarrie McCarthy
Carrie McCarthy
EBEmily Branstad
Emily Branstad
RARanga Niroshan Appuhamy
Ranga Niroshan Appuhamy
The study objective was to determine the effects of rumen-protected methionine (Met) by microencapsulation (RPM) on amino acid (AA) supply to the udder, milk production, and manure nitrogen (N) losses of dairy cows. A corn and soybean-based diet deficient in metabolizable Met (~10 g/d) was supplemented with RPM providing 0, 11.0, 19.3, and 27.5 g/d of Met. Dry matter intake (DMI), milk production, plasma essential AA (EAA), mammary plasma flow (MPF), and fecal (FN) and urinary N (UN) outputs (g/d) were determined. The RPM increased linearly milk yield, milk protein yield, and energy corrected milk yield (p < 0.040) without affecting DMI. Milk protein yield increased by 50 g/d for the 19.3 vs. 0 g/d dose (p = 0.006) but the rate of increment decreased for 27.5 g/d dose. Plasma Met, and MPF increased linearly with RPM dose (p < 0.050). Apparent total tract digestibility of crude protein (p = 0.020) and FN (p = 0.081) decreased linearly with RPM. The UN did not change but total manure N decreased linearly with RPM (p = 0.054). The RPM (19.3 g/d) seemed to help cows overcome the metabolizable Met deficiency while mitigating manure N excretions to the environment.

31 March 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
FGFederico Ghiselli
Federico Ghiselli
APAndrea Piva
Andrea Piva
EGEster Grilli
Ester Grilli
Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) involves the interplay of hepatic lipid accumulation and immune-mediated inflammatory signaling, yet human-relevant in vitro systems that capture both processes simultaneously in a scalable format remain limited. The objective of this study was to develop and characterize a matrix-free 3D hepatocyte–macrophage co-culture model enabling simultaneous assessment of lipid accumulation and NF-κB-mediated inflammatory activation under glucolipotoxic stress. Methods: A 3D liver co-culture model was established by combining HepG2 hepatocyte-like cells with phorbol 12-myristate 13-acetate (PMA)-differentiated THP-1 macrophage-like cells stably expressing a NF-κB–Luc2 reporter. Spheroids were generated using a hanging-drop method in standard 96-well plates and matured for 8–10 days. Mature spheroids were subjected to acute 24 h glucolipotoxic challenge combining high glucose and palmitic acid and assessed for neutral lipid accumulation, NF-κB reporter activation (luciferase), and macrophage marker expression (qPCR). Results: Time-course characterization demonstrated progressive hepatocyte marker remodeling (albumin, alpha-fetoprotein, CYP3A4) and dynamic macrophage phenotype shifts (CD14, CD206, MARCO, TREM2). Acute glucolipotoxic challenge induced dose-dependent increases in neutral lipid accumulation and NF-κB reporter activation, accompanied by coordinated macrophage-associated transcriptional changes consistent with lipid-handling and tissue-remodeling programs. Post-challenge metabolic activity was retained under the selected stress conditions. As a proof-of-concept demonstration, three botanical extracts showed distinct attenuation profiles across the lipid and inflammatory endpoints. Conclusions: This 3D hepatocyte–macrophage co-culture model provides orthogonal readouts of steatosis and NF-κB-mediated inflammatory activation under glucolipotoxic stress, offering a reproducible, fit-for-purpose screening tool for investigating early glucolipotoxic hepatic responses and evaluating candidate compounds in a defined in vitro setting.